| scholarly article | Q13442814 |
| P50 | author | Rachel Mitchell | Q96193706 |
| P2093 | author name string | Lydia Usha | |
| Melody Cobleigh | |||
| Lela Buckingham | |||
| Jacob Rotmensch | |||
| Kelly Burgess | |||
| P2860 | cites work | Between light and dark, the chimera comes out. | Q50655921 |
| Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer | Q54089896 | ||
| Fetal microchimerism in breast from women with and without breast cancer. | Q54464528 | ||
| Population-based study of risk of breast cancer in carriers of BRCA2 mutation | Q57250754 | ||
| Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program | Q57903119 | ||
| Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage | Q71046679 | ||
| Inactivation of BRCA1 and BRCA2 in ovarian cancer | Q74801177 | ||
| Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers | Q77137456 | ||
| Blood lymphocyte chimerism associated with IVF and monochorionic dizygous twinning: case report | Q80579846 | ||
| Immunosuppression and lung cancer of donor origin after bilateral lung transplantation | Q82531544 | ||
| Fetal microchimerism and cancer | Q82791972 | ||
| Genetic/familial high-risk assessment: breast and ovarian | Q84284656 | ||
| BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families | Q84947430 | ||
| The vanishing twin: a major determinant of infant outcome in IVF singleton births | Q36569566 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers | Q36958682 | ||
| Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance | Q36960980 | ||
| Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening | Q37004478 | ||
| Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation | Q37081117 | ||
| Heredity--venturing beyond genetics | Q37133757 | ||
| A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing | Q37164443 | ||
| Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient | Q37180384 | ||
| Clinical significance of chimerism | Q37451155 | ||
| BRCA1 and its toolbox for the maintenance of genome integrity | Q37507563 | ||
| Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review | Q37579992 | ||
| Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. | Q37742771 | ||
| Novel insights into the link between fetal cell microchimerism and maternal cancers | Q38690719 | ||
| Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. | Q40052411 | ||
| Glioblastoma multiforme of donor origin after renal transplantation: report of a case | Q40710615 | ||
| Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia | Q41119925 | ||
| Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling | Q43232347 | ||
| BRCA phenocopies or ascertainment bias? | Q43232466 | ||
| Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation? | Q44250031 | ||
| A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices | Q46148803 | ||
| Consequences of vanishing twins in IVF/ICSI pregnancies | Q46344037 | ||
| Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. | Q46520947 | ||
| Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group | Q47189470 | ||
| Fetal sex discordance in a monochorionic twin pregnancy following intracytoplasmic sperm injection: A case report of chimerism and review of the literature. | Q47569152 | ||
| Fetal microchimerism in human brain tumors. | Q48108207 | ||
| Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials. | Q48717652 | ||
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
| BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor | Q24555775 | ||
| The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study | Q27644636 | ||
| Cancer susceptibility and the functions of BRCA1 and BRCA2 | Q28217784 | ||
| Fetal microchimerism in women with breast cancer | Q28251536 | ||
| Characterization of BRCA1 and BRCA2 mutations in a large United States sample | Q28383993 | ||
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
| The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews | Q29619407 | ||
| Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. | Q30432372 | ||
| Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic | Q33286372 | ||
| Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex/amplicon size differences | Q33555632 | ||
| Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers | Q33614244 | ||
| The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations | Q33946674 | ||
| BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair | Q34110729 | ||
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality | Q34135443 | ||
| Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
| Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers | Q34548640 | ||
| SGO White Paper on ovarian cancer: etiology, screening and surveillance | Q34622294 | ||
| Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology | Q34689165 | ||
| Microchimerism: covert genetics? | Q34794043 | ||
| Quo vadis chimerism? | Q34890920 | ||
| Secondary mutations of BRCA1/2 and drug resistance | Q34983549 | ||
| No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families | Q35033167 | ||
| Lung cancer during pregnancy involving the products of conception and a review of the literature | Q35136603 | ||
| Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry | Q35609710 | ||
| Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. | Q35643852 | ||
| Microchimerism: an investigative frontier in autoimmunity and transplantation | Q35680696 | ||
| Heterogeneous Distribution of Fetal Microchimerism in Local Breast Cancer Environment | Q35903629 | ||
| Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study | Q35925149 | ||
| Do monochorionic dizygotic twins increase after pregnancy by assisted reproductive technology? | Q35984605 | ||
| Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. | Q36178189 | ||
| Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies | Q36281144 | ||
| Unusual Twinning Resulting in Chimerism: A Systematic Review on Monochorionic Dizygotic Twins. | Q36290704 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | e0195497 | |
| P577 | publication date | 2018-04-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families? | |
| P478 | volume | 13 |
| Q92187296 | Somatic variants of potential clinical significance in the tumors of BRCA phenocopies | cites work | P2860 |
Search more.